Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

262
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
262
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

310
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
310
Analgesia and Pain Management01:25

Analgesia and Pain Management

634
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
634
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

742
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
742
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

163
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
163
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

932
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
932

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suzetrigine: A New, Non-Opioid, Acute Pain Management Agent for Podiatric Physicians.

Journal of the American Podiatric Medical Association·2025
Same author

Connectome of a human foveal retina.

bioRxiv : the preprint server for biology·2025
Same author

Concomitant Use of Spasmolytics and Opioids for Postoperative Pain After Foot and Ankle Surgery: Fair or Foul?

Journal of the American Podiatric Medical Association·2023
Same author

An Appraisal of Opioid Treatment Agreements for the Podiatric Physician.

Journal of the American Podiatric Medical Association·2023
Same author

An Appraisal of Using Opioids in Patients with Opioid Use Disorder.

Journal of the American Podiatric Medical Association·2023
Same author

Two mechanisms for direction selectivity in a model of the primate starburst amacrine cell.

Visual neuroscience·2023
Same journal

Offloading Adherence for Appearance's Sake?

Journal of the American Podiatric Medical Association·2026
Same journal

Effect of Insoles on Plantar Fascia Tension During Running in Individuals with Flatfoot.

Journal of the American Podiatric Medical Association·2026
Same journal

Reducing Lower Extremity Amputations via Peer Support Interventions: A Scoping Review.

Journal of the American Podiatric Medical Association·2026
Same journal

Quantitative Assessment of the Correlation Between 'COVID Toes' Search Volume and COVID-19 Case Incidence and Mortality Dynamics: A Longitudinal Data-Driven Approach.

Journal of the American Podiatric Medical Association·2026
Same journal

Reconsidering Nerve Decompression Surgery in Diabetes Foot Complications.

Journal of the American Podiatric Medical Association·2026
Same journal

Quantification of the Mechanical Response of the Plantar Fascia to Changes in Rearfoot Position.

Journal of the American Podiatric Medical Association·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.2K

Risk Management and Mitigating Risk Opportunities for Opioid Prescribing.

Robert G Smith

    Journal of the American Podiatric Medical Association
    |November 7, 2023
    PubMed
    Summary
    This summary is machine-generated.

    Podiatric physicians must carefully manage opioid prescriptions to reduce diversion and abuse. This review offers risk management strategies for safer opioid prescribing in lower-extremity care to prevent harm.

    More Related Videos

    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
    16:02

    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

    Published on: February 10, 2023

    2.7K
    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
    09:29

    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

    Published on: August 4, 2022

    2.2K

    Related Experiment Videos

    Last Updated: Jul 11, 2025

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
    10:13

    Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

    Published on: November 8, 2024

    2.2K
    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
    16:02

    Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

    Published on: February 10, 2023

    2.7K
    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
    09:29

    Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

    Published on: August 4, 2022

    2.2K

    Area of Science:

    • Medical ethics
    • Pharmacology
    • Public health

    Background:

    • Clinicians have an ethical duty to prescribe opioids responsibly to combat the ongoing opioid abuse epidemic.
    • Podiatric physicians need improved methods for controlling opioid prescriptions and developing effective pain management strategies.

    Approach:

    • This review examines clinical, medical, and legal data to assess the risks associated with opioid prescribing in podiatry.
    • It introduces risk management principles, including root cause analysis, applied to opioid prescribing.
    • Case examples from medical and legal literature illustrate opioid prescription risks.

    Key Points:

    • Opioid diversion and abuse pose significant risks that podiatric physicians must address.
    • Implementing robust risk management is crucial for safe opioid prescribing practices.
    • Mitigation strategies are essential for reducing opioid-related harm, adverse effects, and mortality.

    Conclusions:

    • Podiatric physicians can mitigate opioid harm by adopting comprehensive risk management strategies.
    • Safe opioid prescribing practices are vital for protecting patients and public health.
    • This review provides tools and insights for lower-extremity specialists to enhance opioid safety.